GOMEKLI Trademark

Trademark Overview


On Tuesday, June 13, 2023, a trademark application was filed for GOMEKLI with the United States Patent and Trademark Office. The USPTO has given the GOMEKLI trademark a serial number of 98040426. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 17, 2024. This trademark is owned by SpringWorks Therapeutics Operating Company, Inc.. The GOMEKLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of tumors, cancer, and rare diseases; Pharmaceutical preparations for human use for the treatment of diseases in the oncological and neuro-oncological fields; Pharmaceutical preparations for human use for the treatment of neurofibromatosis; Small molecule therapeutic preparations for human use for the treatment of tumors, cancer, and rare diseases; Small molecule therapeutic preparations for human use for the treatment of diseases in the oncological and neuro-oncological fields; Small molecule therapeutic preparations for human use for the treatment of neurofibromatosis
gomekli

General Information


Serial Number98040426
Word MarkGOMEKLI
Filing DateTuesday, June 13, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment of tumors, cancer, and rare diseases; Pharmaceutical preparations for human use for the treatment of diseases in the oncological and neuro-oncological fields; Pharmaceutical preparations for human use for the treatment of neurofibromatosis; Small molecule therapeutic preparations for human use for the treatment of tumors, cancer, and rare diseases; Small molecule therapeutic preparations for human use for the treatment of diseases in the oncological and neuro-oncological fields; Small molecule therapeutic preparations for human use for the treatment of neurofibromatosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSpringWorks Therapeutics Operating Company, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStamford, CT 06902

Party NameSpringWorks Therapeutics Operating Company, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStamford, CT 06902

Trademark Events


Event DateEvent Description
Friday, June 16, 2023NEW APPLICATION ENTERED
Monday, July 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 2, 2024ASSIGNED TO EXAMINER
Saturday, March 9, 2024NON-FINAL ACTION WRITTEN
Saturday, March 9, 2024NON-FINAL ACTION E-MAILED
Saturday, March 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 10, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, June 10, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, June 17, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, June 17, 2024EXAMINERS AMENDMENT E-MAILED
Monday, June 17, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 17, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, July 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT